Approval for the endeavor zotarolimus-eluting coronary stent on the over-the-wire (otw), rapid exchange (rx), or multi-exchange ii (mx2) stent delivery systems.  The device is indicated for improving coronary luminal diameter in patients with ischemic heart disease due to de novo lesions of length <= 27 mm in native coronary arteries with reference vessell diameters of >= 25 mm to <= 3.5 mm.